Art

J-GLOBAL ID：201802234840460947   Reference number：18A1005350

Serum free IgE guided dose reduction of omalizumab: a case report

オマリズマブの血清遊離IgE誘導用量減少:症例報告【JST・京大機械翻訳】

Author (9)： Gon Yasuhiro (Division of Respiratory Medicine, Nihon University School of Medicine, Itabashiku, Japan) ,  Ito Reiko (Division of Respiratory Medicine, Nihon University School of Medicine, Itabashiku, Japan) ,  Maruoka Shuichiro (Division of Respiratory Medicine, Nihon University School of Medicine, Itabashiku, Japan) ,  Mizumura Kenji (Division of Respiratory Medicine, Nihon University School of Medicine, Itabashiku, Japan) ,  Kozu Yutaka (Division of Respiratory Medicine, Nihon University School of Medicine, Itabashiku, Japan) ,  Hiranuma Hisato (Division of Respiratory Medicine, Nihon University School of Medicine, Itabashiku, Japan) ,  Iida Yuko (Division of Respiratory Medicine, Nihon University School of Medicine, Itabashiku, Japan) ,  Shikano Sotaro (Division of Respiratory Medicine, Nihon University School of Medicine, Itabashiku, Japan) ,  Hashimoto Shu (Division of Respiratory Medicine, Nihon University School of Medicine, Itabashiku, Japan)
Material： Allergy, Asthma & Clinical Immunology (Web)
Volume： 13  Issue： 1  Page： 39  Publication year： 2017 
JST Material Number： U7406A  ISSN： 1710-1492  Document type： Article
Article type： 原著論文  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Abstract/Point： Background Omalizumab is a hum...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A1005350&from=J-GLOBAL&jstjournalNo=U7406A") }}

Thesaurus term： metabasis ,  patient ,  health expenditure ,  asthma ,  *case report ,  therapy ,  *immunoglobulin E ,  antibody ,  bronchial asthma ,  *Serum ,  allergen ,  trough value
Semi thesaurus term： 臨床研究 ,  重症喘息 ,  *オマリズマブ , 【Automatic Indexing@JST】

Author keywords (3)： Bronchial asthma ,  Omalizumab ,  IgE

JST classification (2)： Drug therapy(=pharmacotherapy)for respiratory system diseases  (GI05020J) ,  Clinical application of drugs acting on respiration and respiratory system  (GW08020U)

Reference (10)：

• Allergy; Molecular concepts of IgE-initiated inflammation in atopic and nonatopic asthma; G Menz, S Ying, SR Durham, CJ Corrigan, DS Robinson, Q Hamid, R Pfister, M Humbert, AB Kay; 53; 1998; 15-21; 10.1111/j.1398-9995.1998.tb04934.x; CR1;
• Respir Med; Monitoring free serum IgE in severe asthma patients treated with omalizumab; S Korn, I Haasler, F Fliedner, G Becher, P Strohner, A Staatz, C Taube, R Buhl; 106; 11; 2012; 1494-1500; 10.1016/j.rmed.2012.07.010; CR2;
• Allergol Int; Development of assay for determining free IgE levels in serum from patients treated with omalizumab; R Ito, Y Gon, S Nunomura; 63; S1; 2014; 37-47; 10.2332/allergolint.13-OA-0643; CR3;
• Br J Clin Pharmacol; Omalizumab decreases IgE production in patients with allergic (IgE-mediated) asthma; PKPD analysis of a biomarker, total IgE; PJ Lowe, D Renard; 72; 2; 2011; 306-320; 10.1111/j.1365-2125.2011.03962.x; CR4;
• Allergy; Utility of serum periostin and free IgE levels in evaluating responsiveness to omalizumab in patients with severe asthma; T Tajiri, H Matsumoto, Y Gon, R Ito, S Hashimoto, K Izuhara, M Suzukawa, K Ohta, J Ono, S Ohta, I Ito, T Oguma, H Inoue, T Iwata, Y Kanemitsu, T Nagasaki, A Niimi, M Mishima; 71; 10; 2016; 1472-1479; 10.1111/all.12922; CR5;

Terms in the title (6)： オマリズマブ ,  血清 ,  IgE ,  誘導 ,  量減少 ,  症例報告